Christian Loesche
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Immune and Biological Changes during Treatment in Patients with Nonsegmental Vitiligo and their Relation to Repigmentation.
Journal: The Journal of investigative dermatology
Published: May 16, 2025
Modelling atopic dermatitis in healthy human skin for the characterization of topical compounds.
Journal: Experimental dermatology
Published: November 30, 2023
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial.
Journal: Clinical and translational science
Published: July 20, 2023
Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne.
Journal: The Journal of dermatological treatment
Published: October 28, 2022
IgE Depletion with Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis.
Journal: The Journal of investigative dermatology
Published: April 13, 2022
Disease Association of Anti‒Carboxyethyl Lysine Autoantibodies in Hidradenitis Suppurativa.
Journal: The Journal of investigative dermatology
Published: March 09, 2022
IL-17A is a pertinent therapeutic target for moderate-to-severe hidradenitis suppurativa: Combined results from a pre-clinical and phase II proof-of-concept study.
Journal: Experimental dermatology
Published: January 07, 2022
Human Pharmacokinetics of LYS006, an Oral Leukotriene A4 Hydrolase Inhibitor Displaying Target-Mediated Drug Disposition.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: December 06, 2021
Drug discovery strategies for novel leukotriene A4 hydrolase inhibitors.
Journal: Expert opinion on drug discovery
Published: June 30, 2021
Full exome sequencing of 11 families with Hidradenitis suppurativa.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 26, 2020
Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4.
Journal: The Journal of investigative dermatology
Published: January 05, 2020
Population Pharmacokinetic Modeling of Secukinumab in Patients With Moderate to Severe Psoriasis.
Journal: Journal of clinical pharmacology
Published: July 14, 2016
Last Updated: 09/26/2026